Functional interaction between immune checkpoints and lipid metabolism in the development of arteriosclerosis obliterans [PDF]
Frontiers in ImmunologyArteriosclerosis obliterans (ASO) is a chronic vascular disease characterized by narrowing or occlusion of the vascular lumen. Its pathogenesis is complex and closely associated with lipid metabolism disorders and chronic inflammation.
Cui Liyuan
exaly +5 more sources
To elucidate the effect of Ruanjian Qingmai granules on arteriosclerosis obliterans from the perspective of cholesterol efflux [PDF]
Frontiers in MedicineAim of the study To investigate the effect of Ruanjian Qingmai granules (RJQM) on arteriosclerotic obliterans (ASO) and identify its potential bioactive components.
Tianhua Yan +2 more
exaly +3 more sources
Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans [PDF]
Pharmacogenomics and Personalized Medicine, 2023 Yu Zhou,1,* Huoying Cai,1,* Lin Huang,1,* Mingshan Wang,1 Ruiming Liu,2 Siwen Wang,1 Yuansen Qin,1 Chen Yao,1 Zuojun Hu1 1Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular ...
Zhou Y +8 more
doaj +3 more sources
HSPB1 Regulates Autophagy and Apoptosis in Vascular Smooth Muscle Cells in Arteriosclerosis Obliterans [PDF]
Cardiovascular Therapeutics, 2022 Objective. Small heat shock protein-1 (HSPB1) is a small heat shock protein that participates in many cellular processes and alleviates stress-induced cell injury.
Keqin Chen +8 more
doaj +3 more sources
Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans [PDF]
Journal of Health, Population and Nutrition, 2023 Objective To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO).
You-Yuan Yuan +8 more
doaj +3 more sources
Journal of Investigative Surgery, 2021 Objective This study aims to investigate the role of endothelin-1 (ET-1) and C-reactive protein (CRP) in restenosis after intervention of lower extremity arteriosclerosis obliterans. Methods The present prospective observational study included a total of
Weishuai Lian, Yifeng Yuan
exaly +3 more sources
Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans [PDF]
Frontiers in Cardiovascular Medicine, 2022 Background Patients with lower extremity arteriosclerosis obliterans (LEASO) are more likely to appear to be associated with adverse cardiovascular outcomes.
, Jun Wang, Fuding Guo
exaly +3 more sources
The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis [PDF]
Frontiers in Surgery, 2023 ObjectiveThis study explored the correlation between serum HMGB1 levels and postoperative vascular restenosis in patients with lower extremity arteriosclerosis obliterans (LEASO).MethodsA total of 362 patients LEASO who received vascular intervention ...
Bo Yang, Zhang Xiaping, Zhang Xiaping
doaj +3 more sources
MicroRNA-30a-3p: a potential noncoding RNA target for the treatment of arteriosclerosis obliterans. [PDF]
Aging (Albany NY), 2023 An increasing number of studies have shown that noncoding RNAs are involved in cardiovascular diseases. Our study shows that the expression of microRNA-30a-3p (miR-30a-3p) in patients with arteriosclerosis obliterans (ASO) of the lower extremities is ...
Zhang M +5 more
europepmc +2 more sources
Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans. [PDF]
Dis Markers, 2023 Objective To investigate the relationship between angiotensin II (Ang II), vascular endothelial growth factor (VEGF), and arteriosclerosis obliterans (ASO).
Liu Y +5 more
europepmc +2 more sources